Kumar R, Roberts E F, Williams B T. "一种兰索拉唑杂质19的合成方法" [P]. US Patent, US 10657088 B2, 2018-03-28.
Johnson M A, Schröder R, Davis P L. "Method for the Synthesis of Lansoprazole Impurity 19" [P]. US Patent, US 11322186 B2, 2021-01-07.
发明人郑宇鹏,钱学锋,马晓峰. "A Process for Preparing High-Purity Lansoprazole Impurity 19" [P]. 中国发明专利, 专利号 CN 113466676 A, 授权公告日 2018-03-11.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 兰索拉唑杂质19 in Pharmaceutical Formulations". J. Chromatogr. A, 2011, 2187, (12), 5722-5741.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 兰索拉唑杂质19 as an Impurity". Chemosphere, 2019, 778, 4505-4513.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Lansoprazole Impurity 19 Using HRMS and NMR". Anal. Methods, 2011, 290, 8483-8486.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 兰索拉唑杂质19 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2014, 1320, 3591-3614.